Corporate press release
July 21, 2026
Strong second quarter: GEA raises full-year guidance for 2026
Against the backdrop of a very strong operational performance, GEA substantially exceeded both its prior-year figures and analyst expectations in the second quarter of the current fiscal year.
Based on preliminary figures, GEA achieved a 14.2 percent year-over-year increase in order intake in the second quarter of 2026 to €1.49 billion (VARA consensus: €1.41 billion); organic order intake increased by 15.4 percent. Revenue increased by 10.0 percent year-over-year to €1.44 billion (VARA consensus: €1.38 billion), with organic revenue growth amounting to 11.0 percent (VARA consensus: 6.3 percent). EBITDA before restructuring expenses increased year-over-year by 15.6 percent to €250 million (VARA consensus: €233 million), while the corresponding EBITDA margin improved from 16.5 percent in the prior-year quarter to 17.4 percent (VARA consensus: 16.9 percent).
Due to this very strong performance and the positive outlook for the second half of 2026, GEA is raising its full-year guidance as follows:
“In the first half of 2026, we significantly accelerated our revenue growth. Order intake grew even more strongly. With these achievements, we are providing a sustainable foundation for further profitable growth,” said GEA CEO Stefan Klebert.
The company publishes its complete half-year financial report on August 10th, 2026.
VARA-consensus as of July 15th, 2026
| GEA Group | Q2 2026 | Q2 2025 | Q1-Q2 2026 | Q1-Q2 2025 |
|---|---|---|---|---|
| Order Intake - Reported (EUR billion) | 1.49 | 1.31 | 2.95 | 2.72 |
| Order Intake - Organic Growth | 15.4% | 10.7% | ||
| Sales - Reported (EUR billion) | 1.44 | 1.31 | 2.72 | 2.57 |
| Sales - Organic Growth | 11% | 8.2% | ||
| EBITDA bf. restr. (EUR million) | 250 | 217 | 456 | 415 |
| EBITDA bf. restr. in % | 17.4% | 16.5% | 16.8% | 16.1% |
| ROCE (L4Q) in % | 36.8% | 35.3% | 36.8% | 35.3% |
| EPS as reported (EUR) | 0.70-0.80 | 0.66 | 1.30-1.40 | 1.23 |
GEA is one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries.
The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components and comprehensive services. For instance, every second pharma separator for essential healthcare products such as vaccines or novel biopharmaceuticals is produced by GEA. In food, every fourth package of pasta or every third chicken nugget are processed with GEA technology.
With more than 18,000 employees, the group generated sales of about EUR 5.5 billion in more than 150 countries in the 2025 fiscal year. GEA plants, processes, components and services enhance the efficiency and sustainability of customers’ production. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: ”Engineering for a better world.”
GEA is listed on the German DAX, the European STOXX® Europe 600 Index and is also a constituent of the leading sustainability indices DAX 50 ESG, MSCI Global Sustainability and Dow Jones Best-in-Class World.